('ich', 85);('asd', 28);('eeg', 23);('intracerebral hemorrhage', 20);('ass', 19);('stroke', 15);('neurology', 14);('lyon', 13);('electrographic seizures', 13);('epilepsia', 13);('seizures', 11);('levetiracetam', 9);('france', 8);('asds', 8);('neurocrit care', 7);('j clin neurophysiol', 7);('early seizures', 6);('retrospective', 6);('pds', 6);('lpds', 6);('status epilepticus', 6);('incidence', 6);('hirsch lj', 6);('claassen j', 6);('intracerebral h emorrhage', 5);('functional outcome', 5);('acute phase', 5);('late seizures', 5);('figure', 5);('early', 5);('poor outcome', 5);('clinical', 5);('intracerebral haemorrhage', 5);('jr.', 5);('connolly es', 5);('spontaneous intracerebral hemorrhage', 5);('hospices civils', 4);('epilepsy', 4);('ilae', 4);('mri', 4);('according', 4);('periodic discharges', 4);('long term outcome', 4);('seizure', 4);('antiseizure drugs', 4);('greenberg sm', 4);('hauser wa', 4);('engel j', 4);('antiepileptic drugs', 4);('epileptic', 4);('phenytoin', 4);('laurent derex', 3);('md', 3);('phd', 3);('laure peter', 3);('croix', 3);('neuronal injury', 3);('acute symptomatic seizures', 3);('primary prevention', 3);('seizure prophylaxis', 3);('patients [', 3);('high risk', 3);('ischemic stroke [', 3);('studies', 3);('electrographic', 3);('delayed', 3);('us [', 3);('long -term survivors', 3);('cave', 3);('interictal patterns', 3);('months [', 3);('clinical seizures', 3);('stroke organisation', 3);('post -stroke seizures', 3);('heart association/american stroke', 3);('rct', 3);('management', 3);('meta -analysis', 3);('beghi e', 3);('rosand j', 3);('holtkamp', 3);('hesdorffer dc', 3);('nuwer mr', 3);('acute', 3);('woo d', 3);('broderick jp', 3);('cordonnier', 3);('sheth kn', 3);('naidech', 3);('emerson rg', 3);('mayer sa', 3);('rossi', 3);('herman st', 3);('hantus', 3);('guideline', 3);('lancet', 3);('epilepsy res', 3);('prospective', 3);('sylvain rheims', 2);('sleep medicine', 2);('respiratory disease', 2);('-rousse hospital', 2);('orcid', 2);('e-mail', 2);('non -convulsive seizures', 2);('alcohol abuse', 2);('increase intracranial pressure', 2);('clinical outcome', 2);('routine use', 2);('seizure medication', 2);('term settings', 2);('peach', 2);('nct', 2);('consent', 2);('severe disability', 2);('international league', 2);('against epilepsy', 2);('early seizure', 2);('general recurrence risk', 2);('different risk factors', 2);('small vessel disease', 2);('ic h', 2);('subclinical seizures [', 2);('consecutive patients', 2);('underwent ceeg', 2);('convulsive', 2);('ceeg [', 2);('retrospective study', 2);('post -stroke epilepsy [', 2);('risk factors', 2);('elderly [', 2);('electrographic ictal', 2);('cla', 2);('peds', 2);('poor outcome [', 2);('patient s', 2);('prospective study', 2);('epileptic findings', 2);('new onset epilepsy', 2);('seizures [', 2);('clinical neurophysiology', 2);('dry cap electrode', 2);('hemorrhagic stroke', 2);('observational studies', 2);('battey', 2);('rcts', 2);('eso', 2);('current guidelines', 2);('antiseizure medication', 2);('years [', 2);('seizure recurrence', 2);('patients', 2);('carbamazepine [', 2);('klijn cj', 2);('systematic review', 2);('al', 2);('salman r', 2);('j neurol neurosurg psychiatry', 2);('consoli d', 2);('anderson', 2);('ayres', 2);('viswanathan', 2);('pt', 2);('christensen h', 2);('eur stroke j', 2);('forsgren', 2);('tomson t', 2);('fisher rs', 2);('moshe sl', 2);('wiebe', 2);('pitkanen', 2);('vezzani', 2);('szaflarski jp', 2);('de herdt v', 2);('henon h', 2);('leys d', 2);('arch neurol', 2);('batjer hh', 2);('antiepileptic drug', 2);('gilmore ej', 2);('jette n', 2);('primary intracerebral hemorrhage', 2);('tatlisumak t', 2);('predictors', 2);('j crit care', 2);('dworetzky ba', 2);('lee jw', 2);('gaspard n', 2);('kaplan pw', 2);('fountain nb', 2);('drislane fw', 2);('epileptiform discharges', 2);('lateralized periodic discharges', 2);('injury', 2);('schmidt jm', 2);('ann neurol', 2);('cole aj', 2);('punia v', 2);('bena j', 2);('suppl', 2);('intracranial hemorrhage', 2);('bleck tp', 2);('epilepsy curr', 2);('epilepsy behav', 2);('hemphill jc', 2);('becker k', 2);('macdonald rl', 2);('messe sr', 2);('mitchell ph', 2);('heart', 2);('guidelines', 2);('healthcare professionals', 2);('goldstein jn', 2);('stroke n', 2);('medical research council', 2);('gilad r', 2);('boaz', 2);('sadeh', 2);('lampl y', 2);('taylor', 2);('cognitive outcome', 2);('comparative trial', 2);('toni d', 2);('status', 2);('shinnar', 2);('lowenstein d', 2);('antiepileptic drug withdrawal', 2);('randomized', 2);('valproic', 2);('neurological', 1);('claude bernard lyon', 1);('healthcare performance', 1);('reshape', 1);('inserm u1290', 1);('functional neur', 1);('epileptology', 1);('lyon neuroscience', 1);('research center', 1);('inserm u1028', 1);('cnrs umr', 1);('corresponding', 1);('uthor s', 1);('eurological hospital', 1);('hospices', 1);('c ivils', 1);('pinel', 1);('bron', 1);('c edex', 1);('laurent.derex @ chu -lyon.fr dr.', 1);('grande', 1);('laure.peter -derex @ chu -lyon.fr', 1);('abstract seizures', 1);('continuous electroencephalogram', 1);('risk factors f', 1);('cortical location', 1);('intraventricular h emorrhage', 1);('total h emorrhage volume', 1);('sudden blood pressure fl uctuations', 1);('metabolic demand', 1);('recent studies', 1);('prognostic fac tors', 1);('baseline h emorrhage volume', 1);('th', 1);('available scientific evidence', 1);('tri als', 1);('i n patients', 1);('keyw', 1);('intracerebral', 1);('seizu', 1);('antiseizure', 1);('declaration funding', 1);('conflicts', 1);('principal investigator', 1);('clinicaltrials.gov', 1);('availability', 1);('code', 1);('ethics', 1);('introduction intracerebr', 1);('likely re', 1);('disruptive effect', 1);('neuronal networks', 1);('edema [', 1);('long -term se quelae', 1);('late post -stroke epilepsy [', 1);('g oal', 1);('available literature', 1);('terminology seizures', 1);('brain injuries', 1);('time point', 1);('rence [', 1);('week [', 1);('previously', 1);('structural lesion', 1);('epilepsy [', 1);('post-stroke epilepsy [', 1);('recurrent seizures', 1);('mechanical effects', 1);('disruptio n', 1);('cortical networks', 1);('h ematoma', 1);('properties and/or irritation', 1);('blood metabolism', 1);('subtle cortical', 1);('underlyi ng cerebral', 1);('time [', 1);('cortical irritat ion', 1);('hemosiderin depositions', 1);('inflammatory processes', 1);('epileptogenesis [', 1);('epidemiology', 1);('ich seizures', 1);('comparisons', 1);('different patient populations', 1);('seizure criteria', 1);('-up periods', 1);('prospective studies', 1);('monitor patients', 1);('intensive c', 1);('acute phas e [', 1);('continuous electroencephal ography', 1);('intensive care unit', 1);('seizures occurr', 1);('convulsive seizures', 1);('likely overestimates', 1);('clinical seizure', 1);('cortical surface', 1);('electrographic seizur es', 1);('deep hemorrhages', 1);('s eizures', 1);('% vs', 1);('ct', 1);('enhance detection rates', 1);('valuable approach', 1);('valid information', 1);('true incidence rates', 1);('acute seizures', 1);('i n', 1);('new -onset post -stroke epilepsy', 1);('cumulative incidence', 1);('survivors devel op', 1);('additional us [', 1);('cumulative risk', 1);('prospective cohort', 1);('consecutive adults', 1);('lobar brain microbleeds', 1);('potential link', 1);('cerebral amyloid angiopathy', 1);('functional outc ome', 1);('direct influence', 1);('risk', 1);('factor s', 1);('and/or us', 1);('subcortical location', 1);('intraventricular hemorrhage', 1);('total hemorrhage volume', 1);('surgical hematoma evacuation [ 25,15,26,4,27,21,28,29 ]', 1);('helsinki ich', 1);('differences', 1);('clinical manifestation', 1);('underestimation o f epilepsy incidence', 1);('clinical seizure manifestations', 1);('larger ich', 1);('extensive neuronal damage', 1);('subcortical hematoma location', 1);('post -stroke e pilepsy', 1);('ichs', 1);('hypertensive patients [', 1);('post -stroke epilepsy', 1);('early epileptiform activity', 1);('metab olic demand', 1);('secondary brain damage', 1);('glio tic', 1);('clinical score', 1);('late seizure risk prediction', 1);('individual patients', 1);('cortical involvement', 1);('ge <', 1);('volume >', 1);('linear risk increase', 1);('.2 %', 1);('risk scores', 1);('derivation cohort c -statistic', 1);('validation cohort c -statistic', 1);('confidence interval', 1);('furth', 1);('er validation', 1);('ord er', 1);('suboptimal scores predictive performance', 1);('validation cohort raises', 1);('complex biologi cal substrate', 1);('-centre longitudinal cohort study', 1);('recurrent seizure events', 1);('phase [', 1);('genetic risk factors', 1);('severity o f neurologic decit', 1);('predictor s', 1);('recurrent seizure risk', 1);('apoe', 1);('lobar cerebral microbleeds', 1);('stratify risk', 1);('electrophysiological', 1);('clinical symptoms', 1);('and/or ceeg', 1);('patterns', 1);('focal brain injury', 1);('non', 1);('-epileptic patterns consist', 1);('background abnormalities', 1);('interictal', 1);('epileptic activity', 1);('sporadic epileptiform discharges', 1);('rhythmic patterns [', 1);('rhythmic delta activity', 1);('rda', 1);('lrda', 1);('gpds', 1);('grda', 1);('bipds', 1);('ictal', 1);('presen t', 1);('frequency > 4c/s', 1);('patients movements', 1);('ictal [', 1);('particular interest', 1);('n ictal- interictal continuum state', 1);('high prevalence', 1);('non -convulsive seizures [', 1);('abnormal neuronal response', 1);('cortical area', 1);('nervation [', 1);('deleterious effect', 1);('detectable radiological brain lesion [', 1);('prognosis', 1);('prognosis value', 1);('retrospective studie s.', 1);('physiological point', 1);('invasive multimodality', 1);('comatose patients', 1);('spontaneous subarachnoid hemorrhage', 1);('intracortical electrodes', 1);('heart rate', 1);('blood pressure', 1);('respiratory rate [', 1);('high frequency', 1);('brain oxygen level', 1);('sufficient compensatory increase', 1);('cerebral blood flow', 1);('additional brain damage [', 1);('vespa', 1);('non -convulsive', 1);('convulsive seizure', 1);('initial 72h', 1);('neurologic function', 1);('brain edema', 1);('midlin e', 1);('close rate', 1);('assens study', 1);('recent clinical study', 1);('epileptiform abnormalities', 1);('acute ischemic stroke', 1);('poor functional outcome', 1);('dose -dependent relationship [', 1);('s evere conditions', 1);('poor outcomes', 1);('risk o f', 1);('late epilepsy', 1);('ischemic stroke', 1);('background activity asymmetry', 1);('interictal epileptiform discharges', 1);('independent predictor s', 1);('acute brain insult', 1);('hr', 1);('ci:2.9', 1);('ci', 1);('such abnormalities', 1);('neurophysiological biomarkers', 1);('epileptogenesis processes [', 1);('high risk interictal patterns', 1);('ceeg pat terns', 1);('physiological sleep', 1);('topographical organization', 1);('electrophysiological activity', 1);('mortality outcomes', 1);('recordings', 1);('fact tha t', 1);('high number', 1);('neurological symptoms', 1);('hemorrhagic lesion [', 1);('routine eeg', 1);('record seizures', 1);('interictal discharges whereas ceeg', 1);('ceeg sensitivity', 1);('seizures r emain', 1);('intracortical recordings', 1);('research protocols', 1);('comatose patients [', 1);('neurointensive care units', 1);('guideline criteria benefit', 1);('s ociety recommendations', 1);('identify non -convulsive seizures', 1);('non -convulsive status epilepticus', 1);('acute supratentorial brain injury', 1);('mental status', 1);('clinical paroxysmal events', 1);('48h [', 1);('ceeg use', 1);('in-hospital mortality [', 1);('stroke units', 1);('neurovascular intensive care settings', 1);('interictal epileptifor m discharges', 1);('ictal patterns', 1);('select patients', 1);('new devices', 1);('stroke patients [', 1);('anti', 1);('ich acute', 1);('phase m anagement', 1);('ich-related ass', 1);('whether', 1);('seizure drugs', 1);('sds', 1);('primary pharmacological prevention', 1);('debate [ 50,51,5 ]', 1);('sudden blood pressure fluctuations', 1);('series [ 10,18,13 ]', 1);('cohort study', 1);('acute ischemic', 1);('inpatient stay', 1);('year poststroke', 1);('discharge [', 1);('large study', 1);('early neurologic deterioration', 1);('[ 54- 56,28,11 ]', 1);('poor prognosis', 1);('common factors', 1);('large volume s', 1);('relative risks', 1);('wide variation', 1);('agents [', 1);('academic us centers', 1);('o n prophylactic anticonvulsants [', 1);('age', 1);('lobar location', 1);('institutes', 1);('stroke scale', 1);('nihss', 1);('prophylactic anticonvulsant initiation', 1);('rophylactic anticonvulsants', 1);('hospital discharge', 1);('years afterward', 1);('s fever', 1);('liver abnormalities', 1);('cognitive dysfunction', 1);('specific medication', 1);('inhibit neural plasticity', 1);('hinder recovery [', 1);('newer asd', 1);('bett er', 1);('drug -drug interactions', 1);('side effect profiles', 1);('show potential neuroprotective effect [', 1);('post-stroke epilepsy', 1);('clinical trial', 1);('brain injury', 1);('stroke prevents', 1);('mitigates epileptogenesis [', 1);('retrospective studies [', 1);('death [', 1);('observational study', 1);('early use', 1);('signi cant predictors', 1);('interestingly', 1);('multiple factors', 1);('prophylactic levetiracetam', 1);('cognitive outcomes', 1);('d ischarge', 1);('long -term outcome [', 1);('retrospecti ve analys', 1);('recent retros pective study', 1);('prophyla ctic', 1);('fun ctional outcome', 1);('yea r [', 1);('placebo -control', 1);('seizure prevention', 1);('sma ll sample size', 1);('-center trial', 1);('immediat e valproic acid', 1);('p=0.4', 1);('recent systematic review', 1);('meta -analys', 1);('adult patients', 1);('neurological function', 1);('evident seizures', 1);('long -term', 1);('-up [', 1);('unclear risk', 1);('moreove', 1);('significant heterogeneity', 1);('short time horizons', 1);('important seizures', 1);('high variability', 1);('continuous electroen cephalographic', 1);('available data', 1);('clinical guidelines', 1);('prophylactic antiseizure medication', 1);('[ 71,51,5 ]', 1);('administer primary', 1);('cortical involvement [', 1);('association guidelines', 1);('electroencephalogr aphic evidence', 1);('mental status [', 1);('absenc e', 1);('long -term risk', 1);('post -ich epilepsy', 1);('early post -ich period', 1);('aspiration pneum onia', 1);('treatment choice', 1);('pharmacokinetics characteristics', 1);('significant drug -drug interactions', 1);('lev', 1);('lcs', 1);('furthermore', 1);('specific situation', 1);('status epilepticus [', 1);('status epilepticus occurs', 1);('early status epilepticus', 1);('elderly population', 1);('cerebrovascular', 1);('acute symptomatic causes', 1);('overall', 1);('pharmacological management', 1);('line therapy rel', 1);('acute administration', 1);('benzodiazepines [', 1);('refractory status epilepticus', 1);('sodium valproate', 1);('effic acy', 1);('safety outcomes', 1);('adults [', 1);('electrographic epileptic activity treatment indication', 1);('> 2hz and/or', 1);('frequencies and/or', 1);('seizure predictive value', 1);('benzodiazepine trial', 1);('therapeutic decision', 1);('cortical hyperintensities', 1);('long time periods', 1);('true epilepsy incidence', 1);('seizures us', 1);('secondary prophylaxis [', 1);('considerable social consequences', 1);('negative impact', 1);('utmost im portance', 1);('us recurrence r isk', 1);('seizures [ 82,83,15 ]', 1);('guidelines state', 1);('therapy needs', 1);('e cacy', 1);('di erent', 1);('seizure freedom rates', 1);('di er', 1);('account patient profile', 1);('particular attention', 1);('potential atherogenic role', 1);('carbamazepin e [', 1);('seizure recurrence risk', 1);('lesional epilepsy', 1);('% [ 87,88,5 ]', 1);('conclusion', 1);('future directions', 1);('common complication', 1);('cortical hemorrhages', 1);('hospital admission', 1);('fre quency', 1);('therapeutic mana gement', 1);('large prospective studies', 1);('current', 1);('preventive use', 1);('trial evaluates', 1);('potential efficacy', 1);('clinicaltrials.g', 1);('p rospective', 1);('table caption', 1);('asd figure', 1);('clinical epileptic seizure', 1);('epileptic seizure', 1);('transient occurrence', 1);('signs and/or symptoms', 1);('synchronous neuronal activity', 1);('brain [', 1);('generate epileptic seizures', 1);('social consequences', 1);('epileptic seizure [', 1);('practical', 1);('> 24h', 1);('epilepsy syndrome [', 1);('rhythmic discharge', 1);('wave pattern', 1);('definite evolution', 1);('seconds [', 1);('subclinical seizures', 1);('ictal discharges', 1);('clinical signs', 1);('neurological state', 1);('additional seizure symptoms', 1);('potential symptoms', 1);('epileptic discharge', 1);('routine neurological examination', 1);('classification', 1);('references', 1);('1. van', 1);('asch cj', 1);('luitse mj', 1);('rinkel gj', 1);('van der', 1);('tweel', 1);('algra', 1);('case fatality', 1);('ethnic origin', 1);('lancet ne', 1);(':167 -176. doi:10.1016/s1474', 1);('poon mt', 1);('fonville', 1);('long -term prognosis', 1);(':660 -667. doi:10.1136/jnnp', 1);("d'alessandro r", 1);('beretta', 1);('crespi v', 1);('delaj', 1);('gandolfo', 1);('greco g', 1);('neve', 1);('manfredi', 1);('mattana', 1);('musolino r', 1);('provinciali', 1);('santangelo', 1);('specchio lm', 1);('zaccara g', 1);('epistroke g', 1);('acute s ymptomatic seizures', 1);(':1785 -1793. doi:10.1212/wnl.0b013e3182364878', 1);('biffi', 1);('rattani', 1);('gurol em', 1);(':2694 -2705. doi:10.1093/brain/aww199', 1);('benninger', 1);('kalviainen r', 1);('rocamora r', 1);(':103 -115. doi:10.1177/2396987317705536', 1);('carpio', 1);('malmgren k', 1);('sander jw', 1);('recommendation', 1);('acute symptomatic seizure', 1);(':671-675. doi', 1);('acevedo', 1);('arzimanoglou', 1);('bogacz', 1);('jh', 1);('elger ce', 1);('french ja', 1);('glynn', 1);('lee bi', 1);('mathern gw', 1);('perucca e', 1);('scheffer ie', 1);('watanabe', 1);('official re port', 1);('practical clinical definition', 1);(':475 -482. doi:10.1111/epi.12550', 1);('doria jw', 1);('forgacs pb', 1);('implications', 1);('seizures following ischemic', 1);('curr neurol neurosci rep', 1);(':37. doi:10.1007/s11910', 1);('klein p', 1);('dingledine r', 1);('aronica e', 1);('bernard', 1);('blumcke', 1);('boison d', 1);('brodie mj', 1);('brooks', 1);('ar', 1);('forcelli pa', 1);('kaminski rm', 1);('klitgaard h', 1);('kobow k', 1);('lowenstein dh', 1);('pearl pl', 1);('puhakka n', 1);('rog', 1);('ma', 1);('schmidt d', 1);('sillanpaa', 1);('sloviter rs', 1);('steinhauser', 1);('walker mc', 1);('loscher', 1);('commonalities', 1);('epileptogenic processes', 1);('different acute brain insults', 1);(':37 -66. doi:10.1111/epi.13965', 1);('vespa pm', 1);("o'phelan k", 1);('shah', 1);('mirabelli j', 1);('starkman', 1);('kidwell', 1);('saver j', 1);('frazee jg', 1);('mcarthur da', 1);('martin na', 1);('progressive midline', 1);(':1441 -1446. doi:10.1212/0 1.wnl.0000063316.47591.b4', 1);('rackley ay', 1);('kleindorfer do', 1);('khoury j', 1);('miller r', 1);('alwell k', 1);('kissela bm', 1);(':974 -981. doi:10.111 1/j.1528 -1167.2007.01513.x', 1);('dumont', 1);('derambure p', 1);('vonck k', 1);(':1794 -1800. doi:10.1212/wnl.0b013e31823', 1);('zk', 1);('england tj', 1);('mistri ak', 1);('woodhouse lj', 1);('cala', 1);('dineen r', 1);('ozturk', 1);('beridze', 1);('collins r', 1);('bath pm', 1);('sprigg n', 1);('tranexamic acid', 1);(':123 -129. doi:10.1177/2396987320901391', 1);('el', 1);('annegers jf', 1);("o'brien pc", 1);('whisnant jp', 1);('population', 1);('seizure disorders', 1);('cerebral infarction', 1);(':350 -355. doi:10.1212/wnl.46.2.350', 1);('bladin cf', 1);('alexandrov av', 1);('bellavance', 1);('bornstein n', 1);('chambers', 1);('cote r', 1);('lebrun', 1);('pirisi', 1);('norris jw', 1);('prospective multicenter study', 1);(':1617 -1622. doi:10.1001/archneur.57.11.1617', 1);('qureshi ai', 1);('tuhrim', 1);('hondo h', 1);('hanley df', 1);('spontaneous', 1);('n engl j med', 1);(':1450 -1460. doi:10.1056/nejm200105103441907', 1);('neshige', 1);('kuriyama', 1);('yoshimoto t', 1);('takeshima', 1);('himeno t', 1);('takamatsu k', 1);('sato', 1);('ota', 1);('risk factor', 1);('j neurol sci', 1);('322. doi:10.1016/j.jns.2015.09.358', 1);('maciel cb', 1);('review', 1);('utility', 1);('prophylactic anticonvulsant', 1);('critically ill patients', 1);(':2666 -2672. doi:10.1161/strokeaha.116.012410', 1);('beaumont j', 1);('muldoon k', 1);('liotta em', 1);('maas mb', 1);('potts mb', 1);('jahromi bs', 1);('cella d', 1);('prabhakaran', 1);('holl jl', 1);('prophylactic seizure medication', 1);('quality', 1);('crit care med', 1);(':1480 -1485. doi:10.1097/ccm.0000000000003272', 1);('chum', 1);('schmidt', 1);('choi h', 1);('jirsch j', 1);('frontera', 1);('hirsc', 1);('lj', 1);(':1356 -1365. doi:10.1212/01.wnl.0000281664.02615.6c', 1);('madzar d', 1);('kuramatsu jb', 1);('gollwitzer', 1);('lucking h', 1);('kloska sp', 1);('hamer hm', 1);('kohrmann', 1);('huttner hb', 1);(':211 -219. doi:10.1007/s12028', 1);('lahti', 1);('saloheimo p', 1);('huhtakangas j', 1);('salminen h', 1);('juvela', 1);('bode mk', 1);('hillbom', 1);('tetri', 1);('poststroke', 1);(':2169 -2175. doi:10.1212/wnl.0000000000004009', 1);('dequatre', 1);('intracerebral hemorrhages', 1);(':1723 -1725. doi:10.1161/strokeaha.111.000232', 1);('haapaniemi e', 1);('strbian d', 1);('putaala j', 1);('sipi t', 1);('mustanoja', 1);('sairanen t', 1);('curtze', 1);('satopaa j', 1);('roi', 1);('kaste', 1);('meretoja', 1);(':1971 -1976. doi:10.1161/strokeaha.114.004686', 1);('faught e', 1);('peters d', 1);('bartolucci', 1);('moore', 1);('miller pc', 1);(':1089 -1093. doi:10.1212/wnl.39.8.1089', 1);('garrett mc', 1);('komotar rj', 1);('starke rm', 1);('merkow mb', 1);('otten ml', 1);('seizure onset', 1);('long -term antiepileptic therapy', 1);(':335 -339. doi:10.1016/j.jcrc.2008.10.015', 1);('srinivasan', 1);('shin h', 1);('chou sh', 1);('pennell pb', 1);('spontaneous intracerebral hemor rhages', 1);(':512 -516. doi:10.1016/j.seizure.2013.03.011', 1);('passero', 1);('rocchi r', 1);('ulivelli', 1);('vatti g', 1);('spontaneous supratentorial intracerebral hemorrhage', 1);(':1175 -1180. doi:10.1046/j.1528 -1157.2002.003 02.x', 1);('yang tm', 1);('lin wc', 1);('chang wn', 1);('ho jt', 1);('wang hc', 1);('tsai', 1);('shih yt', 1);('lu ch', 1);('j neurosurg', 1);(':87 -93. doi:10.3171/2009.2.jns081622', 1);('laroc', 1);('sm', 1);('gerard e', 1);('svoronos', 1);('mani r', 1);('arif h', 1);('minazad y', 1);('kerrigan jf', 1);('vespa p', 1);('gb', 1);("society 's", 1);('standardized critical care eeg terminology', 1);(':1 -27. doi:10.1097/wnp.0b013e3182784729', 1);('snodgrass sm', 1);('tsuburaya k', 1);('ajmone', 1);('-marsan c', 1);('s tatus epilepticus', 1);(':159 -172. doi:10.1097/00004691', 1);('pohlmann', 1);('-eden b', 1);('hoch db', 1);('cochius ji', 1);('chiappa kh', 1);('periodic', 1);('critical review', 1);(':519 -530. doi', 1);('lin', 1);('literature review', 1);(':189 -198. doi:10.1097/wnp.0000000000000448', 1);('sainju rk', 1);('manganas ln', 1);('petroff oa', 1);('rampal n', 1);('hirsch', 1);('clinical correlates', 1);('prognostic significance', 1);('progressive', 1);('case', 1);(':495 -500. doi:10.1097/wnp.0000000000000206', 1);('perotte', 1);('albers d', 1);('kleinberg', 1);('tu', 1);('badjatia n', 1);('lantigua h', 1);('hripcsak g', 1);('nonconvulsive', 1);('subarachnoid hemorrhage', 1);('multimodal', 1);(':53 -64. doi:1 0.1002/ana.23859', 1);('witsch j', 1);('frey hp', 1);('velazquez', 1);('falo cm', 1);('reznik', 1);('roh d', 1);('agarwal', 1);('park s', 1);('electroencephalographic periodic discharges', 1);('frequency', 1);('-dependent brain', 1);('tissue hypoxia', 1);('jam', 1);('neurol', 1);(':301 -309. doi:10.1001/jamaneurol.2016.5325', 1);('tabaeizadeh', 1);('aboul nour h', 1);('shoukat', 1);('sun h', 1);('jin j', 1);('javed', 1);('kassa', 1);('edhi', 1);('bordbar e', 1);('gallagher j', 1);('moura vj', 1);('ghanta', 1);('shao yp', 1);('rosenthal es', 1);('westover mb', 1);('zafar sf', 1);('burden', 1);('epileptiform activity predicts discharge neurologic outcomes', 1);('severe acute ischemic stroke', 1);('706. doi:10.1007/s12028', 1);('bentes', 1);('martins h', 1);('peralta ar', 1);('morgado', 1);('casimiro', 1);('franco ac', 1);('fonseca ac', 1);('geraldes r', 1);('canh', 1);('pinho emt', 1);('paiva t', 1);('ferro jm', 1);('early eeg', 1);('predicts poststroke epilepsy', 1);(':203 -212. doi:10.1002/epi4.12103', 1);('krishnan', 1);('newey', 1);('c ontinuous electroencephalographic', 1);(':1612 -1620. doi:10.1111/epi.14509', 1);('fitzgerald z', 1);('zhang x', 1);('huynh h', 1);('morrison', 1);('newey cr', 1);('electroencephalographic', 1);('epilepsy development', 1);('acute brain injury', 1);('parallel cohort study', 1);('ann clin transl neurol', 1);(':2230 -2239. doi:10.1002/acn3.50925', 1);('loeb', 1);('dudek fe', 1);('bertram eh', 1);('jensen fe', 1);('mody', 1);('nehlig', 1);('-69. doi:10.1111/epi.12299', 1);('purandare', 1);('ehlert an', 1);('vaitkevicius h', 1);('patient outcome', 1);('intraparenchymal hemorr hages', 1);('-127. doi:10.1016/j.seizure.2018.08.014', 1);('marcellino cr', 1);('lapalme', 1);('-remis s', 1);('rabinstein aa', 1);('van gompel jj', 1);('worrell', 1);('payne et', 1);('hocker', 1);('cortical', 1);('surface intracranial electrodes identify', 1);('relevant seizures', 1);('sc alp', 1);('traumatic intracranial hemorrhage', 1);('epileptic disord', 1);(':551 -556. doi:10.1684/epd.2018.1015', 1);('taccone fs', 1);('horn p', 1);('stocchetti n', 1);('oddo', 1);('neurointensive care', 1);('european society', 1);('intensive care', 1);('recommendations', 1);('consensus statement', 1);('neurointensive care section', 1);('esicm', 1);('intensive care med', 1);('1351. doi:10.1007/s00134', 1);('ghasemi', 1);('azeem mu', 1);('muehlschlegel', 1);('ch', 1);('u f', 1);('henninger n', 1);('prescription', 1);('neurointensive care unit', 1);('-268. doi:10.1016/j.jcrc.2019.01.006', 1);('abend ns', 1);('chapman ke', 1);('dr', 1);('fw', 1);('gerard ee', 1);('hahn', 1);('husain', 1);('laroche sm', 1);('quigg', 1);('riviello jj', 1);('schmitt', 1);('simmons la', 1);('tsuchida tn', 1);('critical care continuous eegtfotacns', 1);('consensus', 1);(':87 -95. doi:10.1097/wnp.0000000000000166', 1);('bermeo', 1);('bringing eeg', 1);('neurocritical care', 1);(':243 -245. doi:10.1177/153575971', 1);('koren j', 1);('herta j', 1);('draschtak', 1);('potzl g', 1);('pirker', 1);('furbass', 1);('hartmann', 1);('kluge t', 1);('baumgartner', 1);('prediction', 1);('early epileptiform discharges', 1);('-289. doi:10.1016/j.yebeh.2015.04.044', 1);('doerrfuss ji', 1);('kilic t', 1);('ahmadi', 1);('weber je', 1);('predictive', 1);(':106486. doi:10.1016/j.yebeh.2019.106486', 1);('morgenstern lb', 1);('huang jn', 1);('selim', 1);('tamargo rj', 1);('cardiovascular n', 1);(':2108 -2129. doi:10.1161/str.0b013e3181ec611b', 1);('anderson cs', 1);('bendok br', 1);('cushman', 1);('fung gl', 1);('scott pa', 1);('selim mh', 1);('cou', 1);(':2032 -2060. doi:10.1161/str.000000000000', 1);('burneo jg', 1);('fang j', 1);('saposnik g', 1);('investigators', 1);('registry', 1);('impact', 1);('canadian multi -centre cohort study', 1);('eur j neurol', 1);(':52 -58. doi:10.1111/j.1468', 1);('leira r', 1);('davalos', 1);('silva y', 1);('gil', 1);('tejada j', 1);('garcia', 1);('castillo j', 1);('stroke project cdgotsns', 1);('neurologic deterioration', 1);(':461 -467. doi:10.1212/01.w nl.0000133204.81153.ac', 1);('kilpatrick cj', 1);('davis sm', 1);('tress bm', 1);('rossiter sc', 1);('hopper jl', 1);('vandendriesen ml', 1);('acute stroke', 1);(':157 -160. doi:10.1001/archneur.1990.00530020053014', 1);('burn j', 1);('dennis', 1);('bamford j', 1);('sanderco', 1);('wade d', 1);('warlow', 1);('oxfordshire', 1);('stroke project', 1);('bmj', 1);(':1582 -1587. doi:10.1136/bmj.315.7122.1582', 1);('labovitz dl', 1);('sacco rl', 1);('prevalence', 1);(':200 -206. doi:10.1212/wnl.57.2.200', 1);('mackey j', 1);('blatsioris ad', 1);('moser eas', 1);('carter rjl', 1);('saha', 1);('stevenson', 1);('hulin al', 1);("o'neill dp", 1);('cohen', 1);('aa', 1);('leipzig tj', 1);('williams ls', 1);('prophylactic anticon', 1);(':220 -228. doi:10.1007/s12028', 1);('troisi e', 1);('paolucci', 1);('silvestrini', 1);('matteis', 1);('vernieri', 1);('grasso mg', 1);('caltagirone', 1);('prognostic', 1);('stroke rehabilitation', 1);('possible rol e', 1);('pharmacological treatment', 1);('acta neurol scand', 1);(':100 -106. doi:10.1034/j.1600 -0404.2002.1o052.x', 1);('shetty ak', 1);('prospects', 1);('neuroprotective drug', 1);('traumatic brain injury', 1);('front neurol', 1);(':172. doi:10.3389/fneur.2013.00172', 1);('temkin nr', 1);('antiepileptogenesis', 1);('seizure prevention trials', 1);(':515 -524. doi:10.1046/j.1528 -1157.2001.28900.x', 1);('marson', 1);('jacoby', 1);('kim', 1);('gamble', 1);('chadwick d', 1);('msg', 1);('immediate', 1);('antiepileptic drug treatment', 1);('early epilepsy', 1);(':2007 -2013. doi:10.1016/s0140', 1);('dabby r', 1);('post intracerebral hemorrhage seizures', 1);('-epileptic treatment', 1);(':227 -231. doi:10.1016/j.eplepsyres.2011.04.002', 1);('sansing lh', 1);('cucchiara bl', 1);('lyden pd', 1);('kasner', 1);('investigators c', 1);('prophylactic', 1);('antiepileptic drug use', 1);(':38 -44. doi:10.1007/s12028', 1);('garg rk', 1);('liebling', 1);('levasseur k', 1);('macken mp', 1);('schu', 1);('su', 1);('anticonvulsant', 1);(':3810 -3815. doi:10.1161/strokeaha.109.559948', 1);('reddig rt', 1);('nixdorf ke', 1);('jensen mb', 1);('prophylactic use', 1);('clin neurol neurosurg', 1);(':895 -897. doi:10.1016/j.clineuro.2011.07.008', 1);('martini sr', 1);('moomaw cj', 1);('koch', 1);('elkind ms', 1);('sung g', 1);('kittner sj', 1);('frankel', 1);('langefeld', 1);('comeau me', 1);('waddy sp', 1);('osborne j', 1);('investigators e', 1);('prophylactic antiepileptic drug', 1);('outcome', 1);('ethnic/racial variations', 1);(':3532 -3535. doi:10.1161/strokeaha.115.010875', 1);('heinrichs rj', 1);('janzen jm', 1);('ehtisham', 1);(':80 -84. doi:10.1007/s12028', 1);('sangha ks', 1);('lindsell cj', 1);('shutter la', 1);('intravenous levetiracetam versus phenytoin', 1);(':165 -172. doi:10.1007/s12028', 1);('battey tw', 1);('falcone gj', 1);('schwab k', 1);('mcnamara ka', 1);('dipucchio zy', 1);('confounding', 1);('retrospective studies', 1);('antiepileptic treatment', 1);(':361 -366. doi:10.1007/s12028', 1);('angriman', 1);('tirupakuzhi vijayaraghavan bk', 1);('dragoi', 1);('lopez soto', 1);('chapman', 1);('scales dc', 1);('prevent seizures', 1);(':1095 -1099. doi:10.1161/strokeaha.118.024380', 1);('steiner t', 1);('beer r', 1);('cord', 1);('onnier c', 1);('csiba', 1);('forsting', 1);('harnof', 1);('krieger d', 1);('mendelow ad', 1);('molina', 1);('montaner j', 1);('overgaard k', 1);('petersson j', 1);('roine ro', 1);('schmutzhard e', 1);('schwerdtfeger k', 1);('stapf', 1);('thomas bm', 1);('unterberg', 1);('wagner', 1);('int j stroke', 1);(':840 -855. doi:10.1111/ijs.12309', 1);('haut sr', 1);('curr opin neurol', 1);(':143 -150. doi:10.1097/wco.0000000000000177', 1);('leppik ie', 1);('-143. doi:10.1111/epi.14497', 1);('rohracher', 1);('reiter dp', 1);('brigo', 1);('kalss g', 1);('thomschewski', 1);('novak h', 1);('zerbs', 1);('dobesberger j', 1);('akhundova', 1);('hofler j', 1);('kuchukhidze g', 1);('leitinger', 1);('trinka e', 1);('elderly -a retrospective study', 1);('-323. doi:10.1016/j.eplepsyres.2016.08.016', 1);('glauser t', 1);('gloss d', 1);('alldredge', 1);('arya r', 1);('bainbridge j', 1);('bar e m', 1);('bleck t', 1);('dodson we', 1);('garrity', 1);('jagoda', 1);('pellock j', 1);('riviello j', 1);('sloan e', 1);('treiman dm', 1);('evidence', 1);('convulsive status epilepticus', 1);('adults', 1);('epi', 1);('lepsy society', 1);(':48 -61. doi:10.5698/1535', 1);('chamberlain jm', 1);('kapur j', 1);('holsti', 1);('babcock', 1);('rogers', 1);('barsan', 1);('cloyd j', 1);('conwit r', 1);('meinzer', 1);('cock h', 1);('underwood e', 1);('connor jt', 1);('silbergleit r', 1);('neurological emergencies', 1);('pediatric emergency care applied', 1);('network', 1);('efficacy', 1);('age group', 1);('esett', 1);('responsive -adaptive', 1);(':1217 -1224. doi:10.1016/s0140', 1);('bauerschmidt', 1);('rubinos', 1);('approach', 1);(':309 -313. doi:10.1097/wnp.00000000000', 1);('lansberg mg', 1);("o'brien mw", 1);('norbash', 1);('moseley me', 1);('morrell', 1);('albers gw', 1);('partial status epilepticus', 1);(':1021 -1027. doi:10.1212/wnl.52.5.1021', 1);('canas n', 1);('breia p', 1);('soares p', 1);('saraiva p', 1);('calado', 1);('jordao', 1);('vale j', 1);('electroclinical -imagiological spectrum', 1);('long -term outcome', 1);('transient periictal', 1);(':240 -252. doi:10.1016/j.eplepsyres.2010.07.019', 1);('balami js', 1);('buchan', 1);('complications', 1);('intracer ebral haemorrhage', 1);('lancet neurol', 1);(':101 -118. doi:10.1016/s1474', 1);('benn ek', 1);('cascino gd', 1);('acute symptomatic seizure epilepsy', 1);('mortality', 1);('recurrent seizure', 1);(':1102 -1108. doi:10.1111/j.1528 -1167.2008.01945.x', 1);('berger ar', 1);('lipton rb', 1);('lesser ml', 1);('lantos g', 1);('portenoy rk', 1);(':1363 -1365. doi:10.1212/wnl.38.9.1363', 1);('sung cy', 1);('chu ns', 1);(':1273 -1276. doi:10.1136/jnnp.52.11.1273', 1);('bosco d', 1);('postorino p', 1);('galati', 1);('plastino', 1);('perticoni gf', 1);('ottonello', 1);('passarella', 1);('ricci', 1);('neri g', 1);('versus carbamazepine', 1);('late poststroke seizures', 1);('open -label study', 1);('epic project', 1);('cerebrovasc dis', 1);(':282 -289. doi:10.1159/000342669', 1);('rapoport', 1);('dab', 1);('monotherapy', 1);('lamotrigine versus carbamazepine', 1);('poststroke seizure', 1);('clin neuropharmacol', 1);(':189 -195. doi:10.1097/wnf.0b013e3180333069', 1);('mintzer', 1);('skidmore ct', 1);('abidin cj', 1);('morales mc', 1);('chervoneva', 1);('capuzzi dm', 1);('sperling mr', 1);('effects', 1);('c -reactive protein', 1);(':448 -456. doi:10.1002/ana.21615', 1);('randomised', 1);('antiep ileptic drug withdrawal', 1);('lossius mi', 1);('hessen e', 1);('mowinckel p', 1);('stavem k', 1);('erikssen j', 1);('gulbrandsen p', 1);('gjerstad', 1);('consequences', 1);('double -blind study', 1);(':455 -463. doi:10.1111/j.1528 -1167.2007.01323.x', 1);('emde boas', 1);('blume', 1);('elger', 1);('genton p', 1);('lee p', 1);('international bureau', 1);('ibe', 1);(':470 -472. doi:10.1111/j.0013 -9580.2005.66104.x', 1);('kowalski rg', 1);('detection', 1);(':1743 -1748. doi:10.1212/01.wnl.0000125184.88797.62', 1);('design total sample size', 1);('asds outcome mess', 1);('phenytoin levetiracetam phenytoin', 1);('szaflarski', 1);('phenytoin levetiracetam leveti', 1);('gilad', 1);('reddig', 1);('-hospital death', 1);('sheth', 1);('mackey', 1);